IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
Top Cited Papers
- 15 January 2010
- journal article
- research article
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 24 (3) , 241-255
- https://doi.org/10.1101/gad.1874010
Abstract
Innate immune cells can constitute a substantial proportion of the cells within the tumor microenvironment and have been associated with tumor malignancy in patients and animal models of cancer; however, the mechanisms by which they modulate cancer progression are incompletely understood. Here, we show that high levels of cathepsin protease activity are induced in the majority of macrophages in the microenvironment of pancreatic islet cancers, mammary tumors, and lung metastases during malignant progression. We further show that tumor-associated macrophage (TAM)-supplied cathepsins B and S are critical for promoting pancreatic tumor growth, angiogenesis, and invasion in vivo, and markedly enhance the invasiveness of cancer cells in culture. Finally, we demonstrate that interleukin-4 (IL-4) is responsible for inducing cathepsin activity in macrophages in vitro and in vivo. Together, these data establish IL-4 as an important regulator, and cathepsin proteases as critical mediators, of the cancer-promoting functions of TAMs.Keywords
This publication has 48 references indexed in Scilit:
- Anti–interleukin-4 therapyImmunology and Allergy Clinics of North America, 2004
- A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary TumorsCancer Research, 2004
- Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesisCancer Cell, 2004
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004
- Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human DiseasesThe American Journal of Pathology, 2003
- Phase II Trial of Recombinant Human Interleukin-4 in Patients With Advanced Renal Cell Carcinoma: A Southwest Oncology Group StudyJournal of Immunotherapy, 2002
- Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesisCancer Cell, 2002
- Cathepsin L deficiency as molecular defect offurless:hyperproliferation of keratinocytes and pertubation of hair follicle cyclingThe FASEB Journal, 2000
- Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene.Proceedings of the National Academy of Sciences, 1988
- Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenesNature, 1985